Synairgen plc (LON:SNG – Get Free Report)’s share price fell 5.2% on Thursday . The company traded as low as GBX 3.50 ($0.04) and last traded at GBX 3.93 ($0.05). 339,001 shares changed hands during mid-day trading, an increase of 7% from the average session volume of 316,664 shares. The stock had previously closed at GBX 4.15 ($0.05).
Synairgen Trading Down 15.3 %
The company’s 50 day simple moving average is GBX 4.50 and its 200-day simple moving average is GBX 4.46. The firm has a market cap of £7.07 million, a P/E ratio of -117.00 and a beta of -2.23. The company has a quick ratio of 6.35, a current ratio of 6.77 and a debt-to-equity ratio of 0.09.
Synairgen Company Profile
Synairgen plc discovers and develops drugs for respiratory diseases. It develops SNG001, an inhaled interferon beta for the treatment of COVID-19; inhaled interferon beta (IFN-ß), which is in Phase-II clinical trials for the treatment of asthma caused by the common cold and flu; and IFN-ß that is in Phase-II clinical trials for the treatment or prevention of chronic obstructive pulmonary disease.
Recommended Stories
- Five stocks we like better than Synairgen
- Election Stocks: How Elections Affect the Stock Market
- Stock Buybacks Outperform Dividends: Here’s the Key Advantage
- Financial Services Stocks Investing
- Novo Nordisk: A New Boost for GLP-1 Sales on the Horizon
- Want to Profit on the Downtrend? Downtrends, Explained.
- Why Now Is the Ultimate Time to Invest in Oil Stocks
Receive News & Ratings for Synairgen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synairgen and related companies with MarketBeat.com's FREE daily email newsletter.
